Emergence of a plasmid mediated blaVIM-1 in Citrobacter koseri: Report from the SENTRY antimicrobial surveillance program (Italy)

Journal of Chemotherapy

Volumn 21, Issue 1, 2009, Pages 98-100

  Castanheira, Mariana ^a   Debbia, E ^b   Marchese, A ^b   Jones, R N ^a,c  

^a JMI LABORATORIES   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE VIM 1; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CHLORAMPHENICOL ACETYLTRANSFERASE; CIPROFLOXACIN; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CITROBACTER KOSERI; GENE SEQUENCE; INTEGRON; INVERTED REPEAT; ITALY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; SPECIES IDENTIFICATION;

EID: 63049087616     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2009.21.1.98     Document Type: Article

References (12)

1. Doran TI. The role of Citrobacter in clinical disease of children: Review. Clin Infect Dis. 1999; 28 (2): 384-94.
2. Lind CR, Muthiah K, Bok AP. Peritumoral Citrobacter koseri abscess associated with parasagittal meningioma. Neurosurgery. 2005; 57 (4): E814.
3. Canario DG, Reme P, Cunha BA. Citrobacter koseri infection and abscess associated with Harrington rods. Am J Infect Control. 2004; 32 (6): 372-4.
4. Clinical and Laboratory Standards Institute. M7-A7, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - seventh edition. Wayne, PA: CLSI, 2006.
5. Riccio ML, Pallecchi L, Docquier JD, et al. Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-β-lactamase from different Italian hospitals. Antimicrob Agents Chemother. 2005; 49 (1): 104-10.
6. VIM-1-carrying integron related to In70.2 from Italian Pseudomonas aeruginosa isolates: A SENTRY Antimicrobial Surveillance Program report. Microb Drug Resist. 2007; 13 (2): 130-4.
7. Szczepanowski R, Krahn I, Linke B, Goesmann A, Puhler A, Schluter A. Antibiotic multiresistance plasmid pRSB101 isolated from a wastewater treatment plant is related to plasmids residing in phytopathogenic bacteria and carries eight different resistance determinants including a multidrug transport system. Microbiology. 2004; 150 (Pt 11): 3613-30.
8. VIM metallo-b-lactamase determinants, Italy. Emerg Infect Dis. 2000; 6 (3): 312-3.
9. Toleman MA, Biedenbach D, Bennett DM, Jones RN, Walsh TR. Italian metallo-b-lactamases: A national problem? Report from the SENTRY Antimicrobial Surveillance Programme. J Antimicrob Chemother. 2005; 55 (1): 61-70.
10. Lombardi G, Luzzaro F, Docquier JD, et al. Nosocomial infections caused by multidrug-resistant isolates of Pseudomonas putida producing VIM-1 metallo-β-lactamase. J Clin Microbiol. 2002; 40 (11): 4051-5.
11. Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother. 2001; 47 (3): 247-50.
12. Clinical and Laboratory Standards Institute. M100-S18, Performance standards for antimicrobial susceptibility testing, 18th informational supplement. Wayne, PA: CLSI, 2008.